SCHEMBL7350441

SCHEMBL7350441

CC(=O)Nc1ccc2c(c1)[nH]c(=O)c(=O)n2CP(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.58
GRIN3B O60391 2/20 0.58
GRIA1 P42261 2/20 0.58
GRIA2 P42262 2/20 0.58
GRIA3 P42263 2/20 0.58
GRIA4 P48058 2/20 0.58
GRIN1 Q05586 2/20 0.58
GRIN2A Q12879 2/20 0.58
GRIN2B Q13224 2/20 0.58
GRIN2C Q14957 2/20 0.58
GRIN3A Q8TCU5 2/20 0.58
ERCC1 P07992 2/20 0.45
FEN1 P39748 2/20 0.45
ERCC4 Q92889 2/20 0.45
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 3/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955880 0.80 GRIA1 (0.71) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL9395757 0.78 SMN1; SMN2 (0.56) GRIA1GRIA2GRIA3GRIA4ERCC1
SCHEMBL7350271 0.77 GRIA1 (0.63) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7356050 0.77 GRIA1 (0.63) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7356582 0.77 GRIN2D (0.63) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7349363 0.77 GRIA1 (0.63) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7355341 0.77 GRIN2D (0.63) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL8609111 0.75 PSMB8 (0.53) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL6745420 0.75 ERCC1 (0.54) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL7357397 0.74 GRIA2 (0.59) GRIN2DGRIN3BGRIA1GRIA2GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288065-B1 CENTRAL NERVOUS SYSTEM DISORDERS; PARKINSON*S AND ALZHEIMER*S DISEASE SCHERING AKTIENGESEELLSCHAFT (DE) 2001-09-11 US disclosed
US-6057304-A Quinoxaline-phosphonic acid derivatives SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed
WO-1993008173-A1 QUINOXALINE DERIVATES WITH AFFINITY FOR QUISQUALATE-RECEPTORS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-29 WO disclosed